Samsung BioLogics says decision pending on making Moderna vaccine as report ignites share

Samsung BioLogics Co Ltd said on Friday no decision has been made yet on producing Moderna Inc's COVID-19 vaccine in South Korea after a newspaper reported the two companies had agreed on a contract manufacturing deal.